Vault-13

Knoll Capital Management, LLC

MIAMI, FL · CIK 1325083 · 13F filing filed 2021-06-14

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$153.5m reported value +8.1% vs Q4 2020
39positions
82.4%in top 10
10 new 2 added 1 reduced 0 sold out vs Q4 2020

This manager withheld holdings under SEC confidential treatment in Q1 2021: the list below may be incomplete, and positions missing since Q4 2020 aren't shown as sold out.

Holdings, Q1 2021

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 BIOHAVEN PHARMACTL HLDG CO L COM BHVN BHVN 856,844 $58.6m38.16% 38.16% ReducedShares held: Q2 2020 857.5k, Q3 2020 857.5k, Q4 2020 857.5k, Q1 2021 856.8k -650 -650 -0.1%
2 APPLIED THERAPEUTICS INC COM APLT APLT 1,025,464 $19.2m12.53% 12.53% AddedShares held: Q2 2020 650.2k, Q3 2020 735.0k, Q4 2020 851.6k, Q1 2021 1.0m +173.9k +173,913 20.4%
3 CORBUS PHARMACEUTICALS HLDGS COM CRBP CRBP 5,045,870 $9.9m6.48% 6.48% UnchangedShares held: Q2 2020 5.0m, Q3 2020 5.0m, Q4 2020 5.0m, Q1 2021 5.0m
4 Orgenesis, Inc. COM COM 1,316,364 $7.5m4.91% 4.91% UnchangedShares held: Q2 2020 1.3m, Q3 2020 1.3m, Q4 2020 1.3m, Q1 2021 1.3m
5 ENTERA BIO LTD SHS ENTX ENTX 1,791,363 $6.8m4.45% 4.45% AddedShares held: Q2 2020 1.7m, Q3 2020 1.7m, Q4 2020 1.7m, Q1 2021 1.8m +50.0k +50,000 2.9%
6 ALDEYRA THERAPEUTICS INC COM ALDX ALDX 569,405 $6.8m4.41% 4.41% UnchangedShares held: Q2 2020 569.4k, Q3 2020 569.4k, Q4 2020 569.4k, Q1 2021 569.4k
7 EIGER BIOPHARMACEUTICALS INC COM CLDN CLDN 694,232 $6.1m4.00% 4.00% UnchangedShares held: Q2 2020 525.2k, Q3 2020 595.2k, Q4 2020 694.2k, Q1 2021 694.2k
8 ABEONA THERAPEUTICS INC COM COM 2,859,767 $5.4m3.50% 3.50% UnchangedShares held: Q2 2020 2.9m, Q3 2020 2.9m, Q4 2020 2.9m, Q1 2021 2.9m
9 Anavex Life Sciemves Corp COM NEW COM NEW 210,789 $3.2m2.05% 2.05% NewShares held: Q2 2020 0, Q3 2020 0, Q4 2020 0, Q1 2021 210.8k
10 BLACKSTONE GROUP L P COM UNIT LTD BX BX 40,000 $3.0m1.94% 1.94% UnchangedShares held: Q2 2020 40.0k, Q3 2020 40.0k, Q4 2020 40.0k, Q1 2021 40.0k
11 CENTURYLINK INC COM CTL CTL 220,000 $2.9m1.91% 1.91% UnchangedShares held: Q2 2020 220.0k, Q3 2020 220.0k, Q4 2020 220.0k, Q1 2021 220.0k
12 EXICURE INC COM XCUR XCUR 1,277,777 $2.8m1.82% 1.82% UnchangedShares held: Q2 2020 1.3m, Q3 2020 1.3m, Q4 2020 1.3m, Q1 2021 1.3m
13 DOW INC COM DOW DOW 30,000 $1.9m1.25% 1.25% UnchangedShares held: Q2 2020 30.0k, Q3 2020 30.0k, Q4 2020 30.0k, Q1 2021 30.0k
14 CORTEVA INC COM CTVA CTVA 30,000 $1.4m0.91% 0.91% UnchangedShares held: Q2 2020 30.0k, Q3 2020 30.0k, Q4 2020 30.0k, Q1 2021 30.0k
15 SOLIGENIX INC COM COM 787,830 $1.2m0.79% 0.79% UnchangedShares held: Q2 2020 787.8k, Q3 2020 787.8k, Q4 2020 787.8k, Q1 2021 787.8k
16 ALTRIA GROUP INC COM MO MO 22,700 $1.2m0.76% 0.76% NewShares held: Q2 2020 0, Q3 2020 0, Q4 2020 0, Q1 2021 22.7k
17 DUPONT DE NEMOURS INC COM DWDP DWDP 15,000 $1.2m0.76% 0.76% UnchangedShares held: Q2 2020 15.0k, Q3 2020 15.0k, Q4 2020 15.0k, Q1 2021 15.0k
18 CORNING INC COM GLW GLW 26,600 $1.2m0.75% 0.75% NewShares held: Q2 2020 0, Q3 2020 0, Q4 2020 0, Q1 2021 26.6k
19 CVS HEALTH CORP COM CVS CVS 14,500 $1.1m0.71% 0.71% NewShares held: Q2 2020 0, Q3 2020 0, Q4 2020 0, Q1 2021 14.5k
20 ANGION BIOMEDICA CORP COM COM 60,000 $1.1m0.71% 0.71% NewShares held: Q2 2020 0, Q3 2020 0, Q4 2020 0, Q1 2021 60.0k
21 BOOZ ALLEN HAMILTON HLDG COR CL A BAH BAH 13,000 $1.0m0.68% 0.68% NewShares held: Q2 2020 0, Q3 2020 0, Q4 2020 0, Q1 2021 13.0k
22 VMWARE INC CL A COM VMW VMW 6,950 $1.0m0.68% 0.68% NewShares held: Q2 2020 0, Q3 2020 0, Q4 2020 0, Q1 2021 7.0k
23 ARISTA NETWORKS INC COM COM 3,450 $1.0m0.68% 0.68% NewShares held: Q2 2020 0, Q3 2020 0, Q4 2020 0, Q1 2021 3.5k
24 VISA INC COM CL A V V 4,850 $1.0m0.67% 0.67% NewShares held: Q2 2020 0, Q3 2020 0, Q4 2020 0, Q1 2021 4.8k
25 THERMO FISHER SCIENTIFIC INC COM TMO TMO 2,100 $958.0k0.62% 0.62% NewShares held: Q2 2020 0, Q3 2020 0, Q4 2020 0, Q1 2021 2.1k
26 BIOXCEL THERAPEUTICS INC COM COM 20,000 $863.0k0.56% 0.56% UnchangedShares held: Q2 2020 20.0k, Q3 2020 20.0k, Q4 2020 20.0k, Q1 2021 20.0k
27 ALTIMMUNE INC COM NEW ALT ALT 50,000 $707.0k0.46% 0.46% UnchangedShares held: Q2 2020 0, Q3 2020 0, Q4 2020 50.0k, Q1 2021 50.0k
28 MAVERIX METALS INC COM NEW COM NEW 115,000 $606.0k0.39% 0.39% UnchangedShares held: Q2 2020 0, Q3 2020 115.0k, Q4 2020 115.0k, Q1 2021 115.0k
29 SEABRIDGE GOLD INC COM COM 32,000 $517.0k0.34% 0.34% UnchangedShares held: Q2 2020 0, Q3 2020 32.0k, Q4 2020 32.0k, Q1 2021 32.0k
30 FRANCO NEV CORP COM FNV FNV 3,750 $470.0k0.31% 0.31% UnchangedShares held: Q2 2020 0, Q3 2020 3.8k, Q4 2020 3.8k, Q1 2021 3.8k
31 OSISKO GOLD ROYALTIES LTD COM COM 190,000 $448.0k0.29% 0.29% UnchangedShares held: Q2 2020 0, Q3 2020 190.0k, Q4 2020 190.0k, Q1 2021 190.0k
32 AGNICO EAGLE MINES LTD COM AEM AEM 6,900 $399.0k0.26% 0.26% UnchangedShares held: Q2 2020 0, Q3 2020 6.9k, Q4 2020 6.9k, Q1 2021 6.9k
33 EQUINOX GOLD CORP COM EQX EQX 45,500 $364.0k0.24% 0.24% UnchangedShares held: Q2 2020 0, Q3 2020 45.5k, Q4 2020 45.5k, Q1 2021 45.5k
34 KIRKLAND LAKE GOLD LTD COM KL KL 10,750 $363.0k0.24% 0.24% UnchangedShares held: Q2 2020 0, Q3 2020 10.8k, Q4 2020 10.8k, Q1 2021 10.8k
35 FORTUNA SILVER MINES INC COM COM 43,700 $283.0k0.18% 0.18% UnchangedShares held: Q2 2020 0, Q3 2020 43.7k, Q4 2020 43.7k, Q1 2021 43.7k
36 MAG SILVER CORP COM MAG MAG 17,300 $260.0k0.17% 0.17% UnchangedShares held: Q2 2020 0, Q3 2020 17.3k, Q4 2020 17.3k, Q1 2021 17.3k
37 SILVERCREST METALS INC COM SIL SIL 31,000 $250.0k0.16% 0.16% UnchangedShares held: Q2 2020 0, Q3 2020 31.0k, Q4 2020 31.0k, Q1 2021 31.0k
38 PAN AMERN SILVER CORP COM PAAS PAAS 8,200 $246.0k0.16% 0.16% UnchangedShares held: Q2 2020 0, Q3 2020 8.2k, Q4 2020 8.2k, Q1 2021 8.2k
39 SILVERCORP METALS INC COM SVM SVM 36,500 $179.0k0.12% 0.12% UnchangedShares held: Q2 2020 0, Q3 2020 36.5k, Q4 2020 36.5k, Q1 2021 36.5k

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
ELICIO THERAPEUTICS INC ELTX · 13G · filed 2026-07-08 ELTX 5.3%≈ $4.7m +0.1 pts 13G 2026-07-08